BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng Y, Campbell F, Han K, Theodore D, Deeg M, Huang M, Hamatake R, Lahiri S, Chen S, Horvath G, Manolakopoulos S, Dalekos GN, Papatheodoridis G, Goulis I, Banyai T, Jilma B, Leivers M. Randomized clinical trials towards a single-visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants. J Viral Hepat 2020;27:699-708. [PMID: 32096313 DOI: 10.1111/jvh.13282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Samad AFA, Kamaroddin MF. Innovative approaches in transforming microRNAs into therapeutic tools. WIREs RNA 2022. [DOI: 10.1002/wrna.1768] [Reference Citation Analysis]
2 Laggerbauer B, Engelhardt S. MicroRNAs as therapeutic targets in cardiovascular disease. J Clin Invest 2022;132:e159179. [PMID: 35642640 DOI: 10.1172/JCI159179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gaddam RR, Dhuri K, Kim YR, Jacobs JS, Kumar V, Li Q, Irani K, Bahal R, Vikram A. γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet. J Med Chem 2022. [PMID: 35133835 DOI: 10.1021/acs.jmedchem.1c01831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ruiz-manriquez LM, Ledesma Pacheco SJ, Medina-gomez D, Uriostegui-pena AG, Estrada-meza C, Bandyopadhyay A, Pathak S, Banerjee A, Chakraborty S, Srivastava A, Paul S. A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers. Genes 2022;13:191. [DOI: 10.3390/genes13020191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Bravo Vázquez LA, Moreno Becerril MY, Mora Hernández EO, León Carmona GG, Aguirre Padilla ME, Chakraborty S, Bandyopadhyay A, Paul S. The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential. Molecules 2021;27:211. [PMID: 35011442 DOI: 10.3390/molecules27010211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
6 Huang PS, Liao CJ, Huang YH, Yeh CT, Chen CY, Tang HC, Chang CC, Lin KH. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers (Basel) 2021;13:5361. [PMID: 34771525 DOI: 10.3390/cancers13215361] [Reference Citation Analysis]
7 Kitab B, Kohara M, Tsukiyama-kohara K. Host-Targeting Antivirals for Treatment of Hepatitis C. Advances in Hepatology 2021. [DOI: 10.5772/intechopen.95373] [Reference Citation Analysis]
8 Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 2021;20:629-51. [PMID: 34145432 DOI: 10.1038/s41573-021-00219-z] [Cited by in Crossref: 240] [Cited by in F6Publishing: 269] [Article Influence: 240.0] [Reference Citation Analysis]
9 Khan P, Siddiqui JA, Lakshmanan I, Ganti AK, Salgia R, Jain M, Batra SK, Nasser MW. RNA-based therapies: A cog in the wheel of lung cancer defense. Mol Cancer 2021;20:54. [PMID: 33740988 DOI: 10.1186/s12943-021-01338-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]